S&P 500

5.214,08

0,51%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Alseres Pharmaceuticals Inc (CE) (ALSE)
Alseres Pharmaceuticals Inc (CE) (ALSE) Notícias

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:ALSE

1

Data	Hora	Fonte	Título	Código	Companhia
21/11/2014	19:10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
18/11/2014	18:09	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/08/2014	09:09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
16/05/2014	10:46	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/04/2014	09:52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	18:00	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	18:00	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	17:40	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	17:40	Edgar (US Regulatory)	Annual Report (management Company) (nsar-b)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	17:37	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
08/01/2013	13:21	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/11/2012	09:08	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
29/03/2012	17:50	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/02/2012	19:11	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	19:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	19:00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/06/2011	17:56	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
03/01/2011	18:46	Edgar (US Regulatory)	Amended tender offer statement by Issuer (SC TO-I/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/05/2010	17:53	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
30/04/2010	11:50	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/11/2009	19:44	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
17/07/2009	10:31	Edgar (US Regulatory)	(25-NSE)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)